Evoke Wealth, LLC Biomarin Pharmaceutical Inc Transaction History

Evoke Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$74.28 - $92.69 $142,691 - $178,057	-1,921 Reduced 92.76%	150 $12,000
Q4 2021 Feb 09, 2022	BUY	$71.72 - $91.47 $12,407 - $15,824	173 Added 9.11%	2,071 $183,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $7,776 - $8,888	104 Added 5.8%	1,898 $146,000
Q2 2021 Aug 05, 2021	BUY	$75.51 - $84.79 $28,693 - $32,220	380 Added 26.87%	1,794 $150,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $94,458 - $114,632	1,264 Added 842.67%	1,414 $107,000
Q2 2020 Aug 10, 2020	SELL	$79.55 - $124.22 $9,546 - $14,906	-120 Reduced 44.44%	150 $19,000
Q1 2020 May 07, 2020	BUY	$71.37 - $96.85 $19,269 - $26,149	270 New	270 $22.8 Million
Q4 2019 Feb 07, 2020	SELL	$64.27 - $86.37 $10,925 - $14,682	-170 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $11,458 - $14,468	170 New	170 $11.5 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.